Pain Medicine News’ editor, Donald Pizzi talks with David Craig,

PharmD, BCPS, a clinical pharmacist specialist and director of the Pain and

Palliative Care Specialty Residency at the H. Lee Moffitt Cancer Center and

Research Institute in Tampa, Florida about the FDA’s draft guidance for

manufacturers developing abuse-deterrent opioids.